Novartis India Limited acquires Minipress trademarks from Pfizer for ₹1250 crore
Novartis India · Pharmaceuticals & Biotechnology
What the filing says
- On September 7, 2026, Novartis India approved and executed an agreement to acquire ‘Minipress’ and ‘Minipres’ trademarks and related IP from Pfizer Inc. USA and Pfizer Products Inc. USA
- The total consideration payable is ₹1250.001 billion (₹1250 crore and ₹10 thousand)
- The Minipress XL brand recorded ₹228.6 crore revenue with a 6.3% CAGR over four years, used primarily for hypertension and benign prostatic hyperplasia in India
Original filing
Intimation Regarding The Acquisition Of Trademarks "Minipress" And "Minipres" From Pfizer Inc. USA And Pfizer Products Inc. USA, The Same Is Approved By The Board Of The Company At Their Board Meeting Held Today I.E. September 07, 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Novartis India
- Fundraise / allotmentEvonile Pharma Board to meet on Oct 8, 2026 to consider rights issue fund-raise
Other acquisition / merger filings this fortnight
- Acquisition / mergerKothari Petrochemicals LtdKothari Petrochemicals Ltd informs NSE on NCLT order for amalgamation scheme
- Acquisition / mergerVeranda LearningVeranda Learning announces Board constitution for J.K. Shah Commerce Education Limited
- Acquisition / mergerSai Parenteral'sSai Parenterals Limited completes acquisition of 60% stake in Prathyak Laboratories
- Acquisition / mergerDr Agarwals Eye Hospital LtdDr. Agarwal’s Eye Hospital files update on Scheme of Amalgamation with Dr. Agarwal’s Health Care
- Acquisition / mergerMaithan Alloys LtdMaithan Alloys Limited acquires 2,527,000 shares of HFCL Limited on 1st Oct 2026
- Acquisition / mergerSunteck Realty LtdSunteck Realty subsidiary acquires approx. 4.5 acres land in Borivali West
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.